Express News | UnitedHealth Group : Deutsche Bank Raises Target Price to $632 From $562
Healthcare Stocks at an 'Inflection Point,' Analyst Says
BofA Downgrades Elevance Health On Medicaid Pressure And Lowered Peer Valuations
Wednesday, Elevance Health Inc. (NYSE:ELV) reported second-quarter revenues of $43.2 billion, down 0.4% year-over-year, marginally above the consensus of $43.05 billion. The decrease was driven by
UnitedHealth Group Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/18/2024 20.23% UBS $640 → $680 Maintains Buy 07/17/2024 6.09% Argus Research $570 → $600 Maintains
Market Whales and Their Recent Bets on UNH Options
Deep-pocketed investors have adopted a bullish approach towards UnitedHealth Group (NYSE:UNH), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today.
UBS Adjusts UnitedHealth Group Price Target to $680 From $640, Maintains Buy Rating
UnitedHealth Group (UNH) has an average rating of Buy and price targets ranging from $545 to $680, according to analysts polled by Capital IQ.Price: 570.64, Change: -2.64, Percent Change: -0.46
Express News | UnitedHealth Group Shares Hit Record High, Last up 1.3%
Elevance Extends Losses as BofA Cuts on Medicaid Headwinds
A Quick Look at Today's Ratings for UnitedHealth(UNH.US), With a Forecast Between $591 to $675
On Jul 18, major Wall Street analysts update their ratings for $UnitedHealth(UNH.US)$, with price targets ranging from $591 to $675.Morgan Stanley analyst Erin Wright maintains with a buy rating,
Today's Analyst Rating | Apple Price Target Raised to $260 by CFRA, CFRA Upgrades Microsoft to Buy
Jul 18, Wall Street analysts have updated their stock ratings today including $Apple(AAPL.US)$ and $Microsoft(MSFT.US)$.
3 Reasons to Own UnitedHealth Stock Now, Says Baird Analyst
Express News | UnitedHealth Group Inc : UBS Raises Target Price to $680 From $640
GoodRx Partners With Boehringer Ingelheim to Discount Humira Biosimilar
Berkshire Hathaway Hits Record High; Will US Stocks Shift From Tech-Driven to Value-Driven?
The
UnitedHealth's Strong Q2 Performance and Strategic Initiatives Secure Buy Rating
Jefferies is bullish on UnitedHealth's (UNH.US) long-term growth potential and has upgraded its rating to "buy".
Jefferies upgraded its rating on UnitedHealth from "hold" to "buy" and significantly raised its target price to $647.
Express News | UnitedHealth Group Inc : HSBC Raises Target Price to $610 From $580
UnitedHealth (UNH) Gets a Buy From Cantor Fitzgerald
UnitedHealthcare Says Selected By The State Of Rhode Island To Serve Medicaid Members Through MMCS Program; This Contract Award Will Continue To Provide Access To Coverage And Services Through 2030
UnitedHealthcare has served Rhode Islanders through the MMCS program since 1993; this contract award will continue to provide access to UnitedHealthcare coverage and services through 2030.
Dow Jones Extends All-Time Highs: Blue Chips Post Strongest 6-Day Gain Versus Tech Stocks In 22 Years
The Dow Jones Industrial Average Index reached a new record high of 41,198 points Wednesday, closing 0.6% higher and extending its winning streak to six consecutive sessions in the green.Blue-chip